Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 2 of the 13 calendar months from Oct 2025 to Oct 2026: Jan 2026 and Apr 2026.
- Largest single sale: $1.4M (7,500 shares) of Axsome Therapeutics, Inc. on Jan 21, 2026. Filing
- No sale on record before this period.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Axsome Therapeutics, Inc. (AXSM) | Chief Commercial Officer | Oct 24, 2024 | Apr 23, 2026 |
Recent filings
The last 2 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Apr 22, 2026, Axsome Therapeutics, Inc.: sold 7,500 shares for $1.4M, under a disclosed plan; 7,500 shares acquired by exercising options. 1 filing: 1
- Jan 21, 2026, Axsome Therapeutics, Inc.: sold 7,500 shares for $1.4M, under a disclosed plan; 7,500 shares acquired by exercising options. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.